Interestingly, the APP protein is known to be a CDK5 substrate, and increased levels of CDK5 lead to elevation of APP processing and elevated Aβ plaque production while inhibition of CDK5 improves AD symptoms [36]. This evidence concerns the gene APP and Alzheimer disease.